Exploring the ESKAPE maze: Pneumonias, resistance and therapeutic perspectives

1 Santajit, Sirijan, and Nitaya Indrawattana. “Mechanisms of Antimicrobial Resistance in ESKAPE Pathogens.” BioMed research international vol. 2016 (2016): 2475067. doi:10.1155/2016/2475067 Search in Google Scholar

2 Ablakimova, Nurgul, et al. “Microbial Landscape and Antibiotic-Susceptibility Profiles of Microorganisms in Patients with Bacterial Pneumonia: A Comparative Cross-Sectional Study of COVID-19 and Non-COVID-19 Cases in Aktobe, Kazakhstan.” Antibiotics (Basel, Switzerland) vol. 12,8 1297. 8 Aug. 2023, doi:10.3390/antibiotics12081297 Search in Google Scholar

3 Choby, J E et al. “Hypervirulent Klebsiella pneumoniae - clinical and molecular perspectives.” Journal of Internal Medicine vol. 287,3 (2020): 283-300. doi:10.1111/joim.13007 Search in Google Scholar

4 Martin, Rebekah M, and Michael A Bachman. “Colonization, Infection, and the Accessory Genome of Klebsiella pneumoniae.” Frontiers in cellular and infection microbiology vol. 8 4. 22 Jan. 2018, doi:10.3389/fcimb.2018.00004 Search in Google Scholar

5 Dong, Ning, et al. “Klebsiella species: Taxonomy, hypervirulence, and multidrug resistance.” EBioMedicine vol. 79 (2022): 103998. doi:10.1016/j.ebiom.2022.103998 Search in Google Scholar

6 Wang, Guoying et al. “The Characteristic of Virulence, Biofilm and Antibiotic Resistance of Klebsiella pneumoniae.” International journal of environmental research and public health vol. 17,17 6278. 28 Aug. 2020, doi:10.3390/ijerph17176278 Search in Google Scholar

7 Ramirez, Maria Soledad et al. “Carbapenemases: Transforming Acinetobacter baumannii into a Yet More Dangerous Menace.” Biomolecules vol. 10,5 720. 6 May. 2020, doi:10.3390/biom10050720 Search in Google Scholar

8 Ramirez, Maria Soledad et al. “Carbapenemases: Transforming Acinetobacter baumannii into a Yet More Dangerous Menace.” Biomolecules vol. 10,5 720. 6 May. 2020, doi:10.3390/biom10050720 Search in Google Scholar

9 Tang, Jiaxin, et al. “The Protective Role of Interleukin 17A in Acinetobacter baumannii Pneumonia Is Associated with Candida albicans in the Airway.” Infection and immunity vol. 91,1 (2023): e0037822. doi:10.1128/iai.00378-22 Search in Google Scholar

10 Liu, Ai-Ran, et al. “Role of immunodeficiency in Acinetobacter baumannii associated pneumonia in mice.” Chinese Medical Journal vol. 133,18 (2020): 2161-2169. doi:10.1097/CM9.0000000000001027 Search in Google Scholar

11 Hernandez, Antonio, et al. “INTRAPULMONARY TREATMENT WITH A NOVEL TLR4 AGONIST CONFERS PROTECTION AGAINST KLEBSIELLA PNEUMONIA.” Shock (Augusta, Ga.) vol. 58,4 (2022): 295-303. doi:10.1097/SHK.0000000000001977 Search in Google Scholar

12 Li, Yanping et al. “Klebsiella pneumonia and Its Antibiotic Resistance: A Bibliometric Analysis.” BioMed research international vol. 2022 1668789. 6 Jun. 2022, doi:10.1155/2022/1668789 Search in Google Scholar

13 Chen, I-Ren, et al. “Clinical characteristics and outcomes of 56 patients with pneumonia caused by carbapenemresistant Klebsiella pneumonia.” Journal of Global Antimicrobial Resistance vol. 25 (2021): 326-330. doi:10.1016/j. jgar.2021.03.028 Search in Google Scholar

14 De Oliveira DMP, Forde BM, Kidd TJ, Harris PNA, Schembri MA, Beatson SA, Paterson DL, Walker MJ. Antimicrobial Resistance in ESKAPE Pathogens. Clin Microbiol Rev. 2020 May 13;33(3):e00181-19. Doi: 10.1128/CMR.00181-19. PMID: 32404435; PMCID: PMC7227449. Search in Google Scholar

15 Chang, Ko-Yun, et al. “Clinical Features and Antimicrobial Susceptibility of Pseudomonas aeruginosa and Acinetobacter baumannii Complex Isolates in Intensive Care Patients with Chronic Obstructive Pulmonary Disease and Community-Acquired Pneumonia in Taiwan.” International journal of chronic obstructive pulmonary disease vol. 16 1801-1811. 17 Jun. 2021, doi:10.2147/COPD.S311714 Search in Google Scholar

16 Liang, C-A et al. “Antibiotic strategies and clinical outcomes in critically ill patients with pneumonia caused by carbapenemresistant Acinetobacter baumannii.” Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases vol. 24,8 (2018): 908. e1-908.e7. doi:10.1016/j.cmi.2017.10.033 Search in Google Scholar

17 Zhou, Yangang, et al. “Clinical experience with tigecycline in treating hospital-acquired pneumonia caused by multidrug- resistant Acinetobacter baumannii.” BMC pharmacology & toxicology vol. 20,1 19. 25 Apr. 2019, doi:10.1186/s40360-019-0300-3 Search in Google Scholar

18 Pei, Yongjian, et al. “Nomogram for predicting 90-day mortality in patients with Acinetobacter baumannii-caused hospital-acquired and ventilator-associated pneumonia in the respiratory intensive care unit.” The Journal of International Medical Research vol. 51,3 (2023): 3000605231161481. doi:10.1177/03000605231161481 Search in Google Scholar

19 Russo, Alessandro, et al. “Efficacy of a Fosfomycin-Containing Regimen for Treatment of Severe Pneumonia Caused by Multidrug- Resistant Acinetobacter baumannii: A Prospective, Observational Study.” Infectious diseases and therapy vol. 10,1 (2021): 187-200. doi:10.1007/s40121-020-00357-8 Search in Google Scholar

20 Jeong, Yun-Jeong, et al. “Prospective observational study of the impact of plasma colistin levels in patients with carbapenem-resistant Acinetobacter baumannii pneumonia.” Journal of Global Antimicrobial Resistance vol. 27 (2021): 315-323. doi:10.1016/j. jgar.2021.10.017 Search in Google Scholar

21 Manfi Ahmed, S et al. “Immunological Evaluation of Individuals Infected with Acinetobacter baumannii.” Archives of Razi Institute vol. 77,5 1813-1819. 31 Oct. 2022, doi:10.22092/ARI.2022.357980.2126 Search in Google Scholar

22 Komiya, Kosaku, et al. “Radiological patterns and prognosis in elderly patients with acute Klebsiella pneumoniae pneumonia: A retrospective study.” Medicine vol. 101,32 (2022): e29734. doi:10.1097/MD.0000000000029734 Search in Google Scholar

23 Sreenath, K et al. “Coinfections with Other Respiratory Pathogens among Patients with COVID-19.” Microbiology spectrum vol. 9,1 (2021): e0016321. doi:10.1128/Spectrum.00163-21 Search in Google Scholar

24 Zaidan, Noor et al. “Extensively Drug-Resistant Acinetobacter baumannii Nosocomial Pneumonia Successfully Treated with a Novel Antibiotic Combination.” Antimicrobial agents and chemotherapy vol. 65,11 (2021): e0092421. doi:10.1128/AAC.00924-21 Search in Google Scholar

25 Falcone, Marco, et al. “Cefiderocol- Compared to Colistin-Based Regimens for the Treatment of Severe Infections Caused by Carbapenem-Resistant Acinetobacter baumannii.” Antimicrobial agents and chemotherapy vol. 66,5 (2022): e0214221. doi:10.1128/aac.02142-21 Search in Google Scholar

26 Karakonstantis, Stamatis, et al. “Treatment options for K. pneumoniae, P. aeruginosa, and A. baumannii co-resistant to carbapenems, aminoglycosides, polymyxins, and tigecycline: an approach based on the mechanisms of resistance to carbapenems.” Infection vol. 48,6 (2020): 835-851. doi:10.1007/s15010-020-01520-6 Search in Google Scholar

27 Bassetti, Matteo, et al. “New antibiotics for Gram-negative pneumonia.” European Respiratory Review: An Official Journal of the European Respiratory Society vol. 31,166 220119. 21 Dec. 2022, doi:10.1183/16000617.0119-2022 Search in Google Scholar

28 Deng, Yanling, et al. “Sulbactam combined with tigecycline improves outcomes in patients with severe multidrug-resistant Acinetobacter baumannii pneumonia.” BMC Infectious Diseases vol. 22,1 795. 21 Oct. 2022, doi:10.1186/s12879-022-07778-5 Search in Google Scholar

29 Pulingam, Thiruchelvi, et al. “Antimicrobial resistance: Prevalence, economic burden, mechanisms of resistance and strategies to overcome.” European Journal of pharmaceutical sciences: official journal of the European Federation for Pharmaceutical Sciences vol. 170 (2022): 106103. doi:10.1016/j. ejps.2021.106103 Search in Google Scholar

30 Piperaki ET, Tzouvelekis LS, Miriagou V, Daikos GL. Carbapenem-resistant Acinetobacter baumannii: in pursuit of an effective treatment. Clin Microbiol Infect. 2019 Aug;25(8):951-957. doi: 10.1016/j.cmi.2019.03.014. Epub 2019 Mar 23. PMID: 30914347.) Search in Google Scholar

31 Sorieul, Charlotte, et al. “Glycoconjugate vaccines against antimicrobial-resistant pathogens.” Expert review of vaccines vol. 22,1 (2023): 1055-1078. doi:10.1080/14760584.20 23.2274955 Search in Google Scholar

32 Semenec, Lucie et al. “Cross-protection and cross-feeding between Klebsiella pneumoniae and Acinetobacter baumannii promotes their co-existence.” Nature communications vol. 14,1 702. 9 Feb. 2023, doi:10.1038/s41467-023-36252-2 Search in Google Scholar

33 Ahn, Danielle et al. “Acquired resistance to innate immune clearance promotes Klebsiella pneumoniae ST258 pulmonary infection.” JCI insight vol. 1,17 e89704. 20 Oct. 2016, doi:10.1172/jci. insight.89704 Search in Google Scholar

34 Dumigan, Amy et al. “In vivo single-cell transcriptomics reveal Klebsiella pneumoniae skews lung macrophages to promote infection.” EMBO molecular medicine vol. 14,12 (2022): e16888. doi:10.15252/emmm.202216888 Search in Google Scholar

35 Catalano, Alessia et al. “Antibiotic-Resistant ESKAPE Pathogens and COVID-19: The Pandemic beyond the Pandemic.” Viruses vol. 15,9 1843. 30 Aug. 2023, doi:10.3390/v15091843 Search in Google Scholar